Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.97M | $62.0M | 6.77% | +625.5K | 2026-06-30 |
| Braidwell LP | 8.70M | $54.0M | 5.91% | -1.54M | 2026-06-30 |
| 12 West Capital Management LP | 7.06M | $44.0M | 4.80% | -200.0K | 2026-06-30 |
| Millennium Management LLC | 6.51M | $40.0M | 4.42% | +4.86M | 2026-06-30 |
| Vanguard Capital Management LLC | 5.28M | $32.0M | 3.59% | -166.0K | 2026-06-30 |
| Ophir Asset Management Pty Ltd | 4.83M | $30.0M | 3.28% | -- | 2026-06-30 |
| Renaissance Technologies LLC | 4.61M | $28.0M | 3.13% | +341.8K | 2026-06-30 |
| Deutsche Bank AG\ | 4.30M | $26.0M | 2.92% | +3.45M | 2026-06-30 |
| First Eagle Investment Management, LLC | 3.67M | $22.0M | 2.49% | +1.15M | 2026-06-30 |
| Geode Capital Management, LLC | 3.13M | $19.0M | 2.13% | +301.7K | 2026-06-30 |
